Halioua-Haubold, C., Jolly, J., Smith, J., Villanueva, R., Brindley, D., & MacLaren, R. (2019). Potential lifetime quality of life benefits of choroideremia gene therapy: Projections from a clinically informed decision model. Springer Nature.
Citación estilo ChicagoHalioua-Haubold, C-L, JK Jolly, JA Smith, R. Villanueva, DA Brindley, and RE MacLaren. Potential Lifetime Quality of Life Benefits of Choroideremia Gene Therapy: Projections from a Clinically Informed Decision Model. Springer Nature, 2019.
Cita MLAHalioua-Haubold, C-L, et al. Potential Lifetime Quality of Life Benefits of Choroideremia Gene Therapy: Projections from a Clinically Informed Decision Model. Springer Nature, 2019.
Warning: These citations may not always be 100% accurate.